Mutations in CHMP2B are not a cause of frontotemporal lobar degeneration in Finnish patients

European Journal of Neurology

Volumn 17, Issue 11, 2010, Pages 1393-1395

  Kaivorinne, A L ^a,b   Kruger J ^a,b   Udd, B ^c,d,e   Majamaa, K ^a,b   Remes, A M ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

Chromatin modifying protein 2B gene; Dementia; Frontotemporal lobar degeneration; Genetics

Indexed keywords

CHROMATIN MODIFYING PROTEIN 2B; CHROMOSOME PROTEIN; PROGRANULIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FAMILY HISTORY; FEMALE; FINLAND; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; HEREDITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; ONSET AGE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FEMALE; FINLAND; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; MALE; MIDDLE AGED; MUTATION; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC;

EID: 78650429353     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03028.x     Document Type: Article

References (22)

1. Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol 2005; 4: 771-780.
2. Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007; 114: 5-22.
3. Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006; 351: 602-611.
4. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-133.
5. Mackenzie IR, Foti D, Woulfe J, et al. Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. Brain 2008; 131: 1282-1293.
6. Neumann M, Rademakers R, Roeber S, et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 2009; 132: 2922-2931.
7. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702-705.
8. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442: 916-919.
9. Cruts M, Gijselinck I, Van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006; 442: 920-924.
10. Watts GD, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004; 36: 377-381.
11. Skibinski G, Parkinson NJ, Brown JM, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005; 37: 806-808.
12. Parkinson N, Ince PG, Smith MO, et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 2006; 67: 1074-1077.
13. Van der Zee J, Urwin H, Engelborghs S, et al. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum Mol Genet 2008; 17: 313-322.
14. Lindquist SG, Braedgaard H, Svenstrup K, et al. Frontotemporal dementia linked to chromosome 3 (FTD-3) - current concepts and the detection of a previously unknown branch of the Danish FTD-3 family. Eur J Neurol 2008; 15: 667-670.
15. Holm IE, Englund E, Mackenzie IR, et al. A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3. J Neuropathol Exp Neurol 2007; 66: 884-891.
16. Cannon A, Baker M, Boeve B, et al. CHMP2B mutations are not a common cause of frontotemporal lobar degeneration. Neurosci Lett 2006; 398: 83-84.
17. Rizzu P, Van Mil SE, Anar B, et al. CHMP2B mutations are not a cause of dementia in Dutch patients with familial and sporadic frontotemporal dementia. Am J Med Genet B Neuropsychiatr Genet 2006; 141B: 944-946.
18. Momeni P, Rogaeva E, Van Deerlin V, et al. Genetic variability in CHMP2B and frontotemporal dementia. Neurodegener Dis 2006; 3: 129-133.
19. Schumacher A, Friedrich P, Diehl-Schmid J, et al. No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia. Neurobiol Aging 2007; 28: 1789-1790.
20. Kaivorinne AL, Krüger J, Kuivaniemi K, et al. Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland. BMC Neurology 2008; 8: 48.
21. Krüger J, Kaivorinne AL, Udd B, et al. Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration. Eur J Neurol 2009; 16: 27-30.
22. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-1554.